Avenue Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Selling, General & Admin	4.18	5.35	2.48	2.35	3.07	4.12	3.62	1	0.84
Research & Development	10.36	2.7	1.25	2.87	23.19	17.7	7.8	1.38	4
Operating Expenses	14.54	8.04	3.74	5.21	26.27	21.82	11.42	2.38	4.84
Operating Income	-14.54	-8.04	-3.74	-5.21	-26.27	-21.82	-11.42	-2.38	-4.84
Interest Expense / Income	0	0	0	0	0	0	0.38	0.61	0.38
Other Expense / Income	-4.16	-4.49	-0.01	-0.06	-0.36	-0.27	0.46	0.19	-
Pretax Income	-10.38	-3.55	-3.73	-5.15	-25.91	-21.55	-12.26	-3.18	-5.23
Net Income	-10.38	-3.55	-3.73	-5.15	-25.91	-21.55	-12.26	-3.18	-5.23
Shares Outstanding (Basic)	11	2	1	1	1	1	0	0	0
Shares Outstanding (Diluted)	11	2	1	1	1	1	0	0	0
Shares Change	384.71%	92.84%	2.97%	4.99%	53.54%	54.32%	131.95%	5.85%	-
EPS (Basic)	-0.98	-1.63	-3.29	-4.65	-24.75	-31.50	-27.75	-16.65	-28.95
EPS (Diluted)	-0.98	-1.63	-3.29	-4.65	-24.75	-31.50	-27.75	-16.65	-28.95
Free Cash Flow	-9.45	-7.6	-3.75	-5.61	-26.26	-18.22	-6.8	-1.63	-0.9
Free Cash Flow Per Share	-0.89	-3.48	-3.31	-5.10	-25.05	-26.68	-15.38	-8.56	-4.97
EBITDA	-10.38	-3.55	-3.73	-5.15	-25.91	-21.55	-11.88	-2.57	-4.84
EBIT	-10.38	-3.55	-3.73	-5.15	-25.91	-21.55	-11.88	-2.57	-4.84

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).